Valuation: Olympus Corporation

Market Cap 1,882B 11.59B 10.13B 9.35B 8.61B 16.24B 1,116B 16.6B 112B 43.93B 547B 43.52B 42.57B P/E 2027 *
19.5x
P/E 2028 * 16.2x
Enterprise Value 1,952B 12.02B 10.51B 9.7B 8.94B 16.84B 1,158B 17.22B 116B 45.58B 567B 45.15B 44.16B EV / Sales 2027 *
1.83x
EV / Sales 2028 * 1.75x
Free-Float
94.53%
Yield 2027 *
1.74%
Yield 2028 * 1.82%
1 day+1.40%
1 week+1.75%
Current month+4.27%
1 month+6.59%
3 months+11.73%
6 months-13.29%
Current year-10.73%
1 week 1,735.5
Extreme 1735.5
1,817
1 month 1,612
Extreme 1612
1,818
Current year 1,302.5
Extreme 1302.5
2,137
1 year 1,302.5
Extreme 1302.5
2,168
3 years 1,302.5
Extreme 1302.5
2,867
5 years 1,302.5
Extreme 1302.5
3,198
10 years 758.75
Extreme 758.75
3,198
Manager TitleAgeSince
Chief Executive Officer 63 2025-05-31
Director of Finance/CFO 59 2026-03-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 69 2023-03-31
Director/Board Member 41 2019-05-31
Director/Board Member 63 2019-05-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.40%+1.75%+5.64%-20.56% 11.42B
-1.84%+1.12%+25.41%+1.47% 202B
-0.67%+2.23%+4.47%-14.41% 145B
-13.18%-14.20%-32.38%-1.36% 142B
-1.73%-2.12%-58.13%-16.71% 66.32B
-2.09%-6.83%+12.77%-7.27% 50.58B
-0.11%+1.53%-24.62%-31.81% 44.81B
-2.78%-1.46%+13.72%+11.91% 38.44B
-2.07%-1.74%+24.57%+37.08% 37.13B
-4.26%-2.87%-17.58%-22.60% 29.89B
Average -2.72%+1.05%-4.61%-6.43% 76.8B
Weighted average by Cap. -3.72%+1.81%-2.82%-5.16%

Financials

2027 *2028 *
Net sales 1,067B 6.57B 5.74B 5.3B 4.88B 9.2B 633B 9.41B 63.32B 24.91B 310B 24.67B 24.13B 1,108B 6.82B 5.96B 5.5B 5.07B 9.56B 657B 9.77B 65.78B 25.87B 322B 25.63B 25.07B
Net income 98.73B 608M 531M 490M 452M 852M 58.56B 871M 5.86B 2.31B 28.68B 2.28B 2.23B 118B 725M 634M 585M 539M 1.02B 69.82B 1.04B 6.99B 2.75B 34.19B 2.72B 2.66B
Net Debt 70.42B 434M 379M 350M 322M 608M 41.77B 621M 4.18B 1.64B 20.46B 1.63B 1.59B 52.07B 321M 280M 259M 238M 449M 30.88B 459M 3.09B 1.22B 15.12B 1.2B 1.18B
Logo Olympus Corporation
Olympus Corp is a Japan-based company mainly engaged in the manufacture and sale of endoscopes, therapeutic equipment, scientific and other products. The Company operates through three business segments. The Endoscope segment provides gastrointestinal endoscopes, surgical endoscopes, and medical services. The Therapeutic Equipment segment provides gastrointestinal treatment instruments, urology products, respiratory products, energy devices, otolaryngology products and gynecology products. The Others segment provides biomaterials and orthopedic instruments. The Company is also engaged in the business activities, including holding companies and financial investments related to each business.
Employees
28,138
Date Price Change Volume
26-07-17 ¥1,771.50 +1.40% 6,334,600
26-07-16 ¥1,747.00 0.00% 3,845,700
26-07-15 ¥1,747.00 -2.62% 3,274,100
26-07-14 ¥1,794.00 +1.04% 3,904,800
26-07-13 ¥1,775.50 +1.25% 3,629,900
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,771.50JPY
Average target price
1,913.08JPY
Spread / Average Target
+7.99%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7733 Stock